Paradigm Capital Management (Nevada)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Sell
4,435
-40
-0.9% -$13.7K 1.38% 22
2026
Q1
$1.57M Sell
4,475
-40
-0.9% -$14.3K 1.44% 20
2025
Q4
$1.48M Buy
4,515
+50
+1% +$15.9K 1.37% 22
2025
Q3
$1.26M Sell
4,465
-553
-11% -$160K 1.25% 24
2025
Q2
$1.4M Buy
5,018
+1,348
+37% +$382K 1.38% 21
2025
Q1
$1.14M Buy
3,670
+95
+3% +$28.1K 1.17% 24
2024
Q4
$932K Buy
3,575
+10
+0.3% +$2.97K 0.87% 30
2024
Q3
$1.15M Buy
+3,565
New +$1.17M 1.1% 25
2022
Q4
$810K Sell
3,085
-4
-0.1% -$1.07K 1.19% 24
2022
Q3
$696K Sell
3,089
-120
-4% -$29.1K 0.93% 25
2022
Q2
$781K Hold
3,209
0.98% 25
2022
Q1
$776K Sell
3,209
-215
-6% -$49.4K 0.78% 30
2021
Q4
$770K Buy
+3,424
New +$723K 0.77% 29

Other funds holding AMGN

Paradigm Capital Management (Nevada)'s AMGN Position: Q2 2026 in Review

Paradigm Capital Management (Nevada) reduced its Amgen (AMGN) stake by 0.89% in Q2 2026, selling an estimated $13.7K and leaving 4,435 shares worth $1.61M. The position accounts for 1.38% of the portfolio, ranked #22.

Paradigm Capital Management (Nevada) first reported a position in AMGN in Q4 2021 and has held it in 13 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Paradigm Capital Management (Nevada) held 4,435 shares of Amgen worth $1.61M as of Q2 2026.
  • Paradigm Capital Management (Nevada) sold 40 Amgen shares in Q2 2026, an estimated $13.7K.
  • Amgen made up 1.38% of Paradigm Capital Management (Nevada)'s portfolio in Q2 2026, its #22 holding.
  • Paradigm Capital Management (Nevada) first reported a position in Amgen in Q4 2021 and has held it in 13 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Paradigm Capital Management (Nevada)'s 13F filing for Q2 2026, filed 14 Aug 2026.